Jumpstart (4 weeks)
Operating model + Board Pack v1
Solutions
Move fast on science with financial control.
For pre‑seed to Series B biotech, we turn trial and CMC plans into cash‑timed, investor‑grade decisions—without slowing you down.
Purpose‑built for clinical-stage biotech
FP&A tuned to trials, CRO SOWs, site ramp, batch plans and grants—not retrofits.
Start fast, scale cleanly
4‑week Jumpstart; then a steady close-to-forecast rhythm that compounds accuracy.
One connected view
We pull ERP/actuals, CRO SOWs, enrollment & batch calendars into a single cash picture.
Audit‑friendly from day one
Assumptions governance and board‑quality packs that stand up in diligence.
Run (subscription)
Rolling forecast, variance, burn bridges, decision memos
Add‑ons
Raise‑Ready; Clinical & CMC Costing
Founders & CEOs
Cash runway + dilution views to time gates and raises.
Finance
Clean close-to-forecast rhythm and board‑ready packs.
Clinical Ops
Enrollment & site ramp tied to cash; vendor cadence visible.
Designed for your stage
- Pre‑IND / IND‑enabling: grant‑aware modeling; batch plans tied to cash
- Phase 1–2: CRO/CMO cadence to burn; site ramp vs. enrollment
- Pre‑A / A / B: investor‑grade reporting; scenario‑driven dilution planning